Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PROCEPT BioRobotics Q2 EPS $(0.35) Beats $(0.41) Estimate, Sales $79.182M Beat $75.921M Estimate

Author: Benzinga Newsdesk | August 06, 2025 04:07pm
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.41) by 15.25 percent. This is a 30 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $79.182 million which beat the analyst consensus estimate of $75.921 million by 4.30 percent. This is a 48.41 percent increase over sales of $53.353 million the same period last year.

Posted In: PRCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist